{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:35:21Z","timestamp":1778621721333,"version":"3.51.4"},"reference-count":45,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>We recently showed that treatment with the CuII-selective chelator, trientine, alleviates heart failure in diabetic rats, improves left ventricular hypertrophy in humans with type 2 diabetes, and increases urinary Cu excretion in both diabetic rats and humans compared with nondiabetic control subjects. In this study, we characterized the homeostasis of Cu and eight other nutritionally essential elements in diabetes under fully residential conditions in male subjects with type 2 diabetes and age-matched control subjects. We then probed elemental balance with oral trientine in a parallel-group, placebo-controlled study in these subjects. Before treatment, there were no detectable between-group differences in the balance of any element, although urinary output of several elements was greater in diabetic subjects. Mean extracellular superoxide dismutase (EC-SOD) activity was elevated in diabetic subjects, and its activity correlated strongly with the interaction between [Cu]serum and HbA1c. Trientine caused the Cu balance to become negative in diabetic subjects through elevated urinary Cu losses and suppressed elevated EC-SOD. Basal urinary Cu predicted urinary Cu losses during treatment, which caused extraction of systemic CuII. We suggest that cardiovascular complications in diabetes might be better controlled by therapeutic strategies that focus on lowering plasma glucose and loosely bound systemic CuII.<\/jats:p>","DOI":"10.2337\/diabetes.54.5.1468","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"1468-1476","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":86,"title":["Demonstration of a Hyperglycemia-Driven Pathogenic Abnormality of Copper Homeostasis in Diabetes and Its Reversibility by Selective Chelation"],"prefix":"10.2337","volume":"54","author":[{"given":"Garth J.S.","family":"Cooper","sequence":"first","affiliation":[{"name":"School of Biological Sciences, Faculty of Science, University of Auckland, New Zealand"},{"name":"Centre for Molecular Biodiscovery, Faculty of Science, University of Auckland, New Zealand"},{"name":"Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand"},{"name":"Human Nutrition Unit, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Kai","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Faculty of Science, University of Auckland, New Zealand"},{"name":"Human Nutrition Unit, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajith M.","family":"Dissanayake","sequence":"additional","affiliation":[{"name":"South Auckland Diabetes Service, Middlemore Hospital, Otahuhu, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona E.","family":"Leahy","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Faculty of Science, University of Auckland, New Zealand"},{"name":"Human Nutrition Unit, University of Auckland, New Zealand"},{"name":"School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine F.","family":"Keogh","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Faculty of Science, University of Auckland, New Zealand"},{"name":"Human Nutrition Unit, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris M.","family":"Frampton","sequence":"additional","affiliation":[{"name":"Department of Medicine, Christchurch Clinical School, University of Otago, Christchurch, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Gamble","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne H.","family":"Brunton","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Faculty of Science, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Baker","sequence":"additional","affiliation":[{"name":"South Auckland Diabetes Service, Middlemore Hospital, Otahuhu, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally D.","family":"Poppitt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand"},{"name":"Human Nutrition Unit, University of Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031218140183700_R1","unstructured":"Halliwell B, Gutteridge JM: Free Radicals in Biology and Medicine. 3rd ed. Oxford, Oxford University Press, 1999"},{"key":"2022031218140183700_R2","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group: MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet\u2008360:23\u201333,2002","DOI":"10.1016\/S0140-6736(02)09328-5"},{"key":"2022031218140183700_R3","doi-asserted-by":"crossref","unstructured":"Monnier VM: Transition metals redox: reviving an old plot for diabetic vascular disease. J Clin Invest\u2008107:799\u2013801,2001","DOI":"10.1172\/JCI12635"},{"key":"2022031218140183700_R4","doi-asserted-by":"crossref","unstructured":"Frau\u0301sto da Silva JJ, Williams RJ: The Biological Chemistry of the Elements: The Inorganic Chemistry of Life. 2nd ed. Oxford, U.K., Clarendon Press, 2001","DOI":"10.1093\/oso\/9780198508472.001.0001"},{"key":"2022031218140183700_R5","doi-asserted-by":"crossref","unstructured":"Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med\u200810:339\u2013352,1991","DOI":"10.1016\/0891-5849(91)90040-A"},{"key":"2022031218140183700_R6","doi-asserted-by":"crossref","unstructured":"Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971\u20131993. Diabetes Care\u200821:1138\u20131145,1998","DOI":"10.2337\/diacare.21.7.1138"},{"key":"2022031218140183700_R7","doi-asserted-by":"crossref","unstructured":"Struthers AD, Morris AD: Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet\u2008359:1430\u20131432,2002","DOI":"10.1016\/S0140-6736(02)08358-7"},{"key":"2022031218140183700_R8","doi-asserted-by":"crossref","unstructured":"Cooper GJ, Phillips AR, Choong SY, Leonard BL, Crossman DJ, Brunton DH, Saafi EL, Dissanayake AM, Cowan BR, Young AA, Occleshaw CJ, Chan YK, Leahy FE, Keogh GF, Gamble GD, Allen GR, Pope AJ, Boyd PD, Poppitt SD, Borg TK, Doughty RN, Baker JR: Regeneration of the heart in diabetes by selective copper chelation. Diabetes\u200853:2501\u20132508,2004","DOI":"10.2337\/diabetes.53.9.2501"},{"key":"2022031218140183700_R9","doi-asserted-by":"crossref","unstructured":"Franz MJ, Bantle JP, Bebbe CA, Brunzell JD, Chaisson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-David E, Mooradian AD, Purnell JQ, Wheeler M: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Review). Diabetes Care\u200825:148\u2013198,2002","DOI":"10.2337\/diacare.25.1.148"},{"key":"2022031218140183700_R10","unstructured":"Clescerl LS, Greenberg AE, Eaton AD: Standard Methods for the Examination of Water and Waste Water. 20th ed. Washington, DC, American Public Health Association, 1998"},{"key":"2022031218140183700_R11","unstructured":"Goldstein H: Multilevel Statistical Models. 3rd ed. London, U.K., Arnold, 2003"},{"key":"2022031218140183700_R12","doi-asserted-by":"crossref","unstructured":"McCulloch CE, Searle SR: Generalized, Linear, and Mixed Models. New York, John Wiley, 2001","DOI":"10.1002\/9780470057339.vag009"},{"key":"2022031218140183700_R13","doi-asserted-by":"crossref","unstructured":"Kodama H, Murata Y, Iitsuka T, Abe T: Metabolism of administered triethylene tetramine dihydrochloride in humans. Life Sci\u200861:899\u2013907,1997","DOI":"10.1016\/S0024-3205(97)00592-4"},{"key":"2022031218140183700_R14","unstructured":"Smith RG, Heise CC, King JC, Costa FM, Kitzmiller JL: Serum and urinary magnesium, calcium and copper levels in insulin-dependent diabetic women. J Trace Elem Electrolytes Health Dis\u20082:239\u2013243,1988"},{"key":"2022031218140183700_R15","doi-asserted-by":"crossref","unstructured":"Ito S, Fujita H, Narita T, Yaginuma T, Kawarada Y, Kawagoe N, Sugiyama T: Urinary copper excretion in type 2 diabetic patients with nephropathy. Nephron\u200888:307\u2013312,2001","DOI":"10.1159\/000046013"},{"key":"2022031218140183700_R16","doi-asserted-by":"crossref","unstructured":"Walter RM Jr, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL: Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care\u200814:1050\u20131056,1991","DOI":"10.2337\/diacare.14.11.1050"},{"key":"2022031218140183700_R17","doi-asserted-by":"crossref","unstructured":"Hurrell RF, Ribas S, Davidsson L: NaFe3+EDTA as a food fortificant: influence on zinc, calcium and copper metabolism in the rat. Br J Nutr\u200871:85\u201393,1994","DOI":"10.1079\/BJN19940113"},{"key":"2022031218140183700_R18","doi-asserted-by":"crossref","unstructured":"Vachette P, Dainese E, Vasyliev VB, Di Muro P, Beltramini M, Svergun DI, De Filippis V, Salvato B: A key structural role for active site type 3 copper ions in human ceruloplasmin. J Biol Chem\u2008277:40823\u201340831,2002","DOI":"10.1074\/jbc.M207188200"},{"key":"2022031218140183700_R19","doi-asserted-by":"crossref","unstructured":"Hellman NE, Gitlin JD: Ceruloplasmin metabolism and function. Annu Rev Nutr\u200822:439\u2013458,2002","DOI":"10.1146\/annurev.nutr.22.012502.114457"},{"key":"2022031218140183700_R20","doi-asserted-by":"crossref","unstructured":"Kehoe CA, Faughman MS, Gilmore WS, Coulter JS, Howard AN, Strain JJ: Plasma diamine oxidase is greater in copper-adequate than copper-marginal or copper-deficient rats. J Nutr\u2008130:30\u201333,2000","DOI":"10.1093\/jn\/130.1.30"},{"key":"2022031218140183700_R21","doi-asserted-by":"crossref","unstructured":"Hambidge M: Biomarkers of trace mineral intake and status. J Nutr\u2008133:948S\u2212955S,2003","DOI":"10.1093\/jn\/133.3.948S"},{"key":"2022031218140183700_R22","doi-asserted-by":"crossref","unstructured":"Milne DB, Nielsen FH: Effects of a diet low in copper on copper-status indicators in postmenopausal women. Am J Clin Nutr\u200863:358\u2013364,1996","DOI":"10.1093\/ajcn\/63.3.358"},{"key":"2022031218140183700_R23","doi-asserted-by":"crossref","unstructured":"Pen\u0303a MM, Lee J, Thiele DJ: A delicate balance: homeostatic control of copper uptake and distribution. J Nutr\u2008129:1251\u20131260,1999","DOI":"10.1093\/jn\/129.7.1251"},{"key":"2022031218140183700_R24","unstructured":"Kadiiska MB, Hanna PM, Hernandez L, Mason RP: In vivo evidence of hydroxyl radical formation after acute copper and ascorbic acid intake: electron spin resonance spin-trapping investigation. Mol Pharmacol\u200842:723\u2013729,1992"},{"key":"2022031218140183700_R25","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med\u2008329:977\u2013986,1993","DOI":"10.1056\/NEJM199309303291401"},{"key":"2022031218140183700_R26","doi-asserted-by":"crossref","unstructured":"Adachi T, Nakamura M, Yamada H, Futenma A, Kato K, Hirano K: Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseases. Clin Chim Acta\u2008229:123\u2013131,1994","DOI":"10.1016\/0009-8981(94)90234-8"},{"key":"2022031218140183700_R27","doi-asserted-by":"crossref","unstructured":"Fukai T, Folz RJ, Landmesser U, Harrison DG: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res\u200855:239\u2013249,2002","DOI":"10.1016\/S0008-6363(02)00328-0"},{"key":"2022031218140183700_R28","doi-asserted-by":"crossref","unstructured":"Adachi T, Inoue M, Hara H, Maehata E, Suzuki S: Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol\u2008181:413\u2013417,2004","DOI":"10.1677\/joe.0.1810413"},{"key":"2022031218140183700_R29","doi-asserted-by":"crossref","unstructured":"Kimura F, Hasegawa G, Obayashi H, Adachi T, Hara H, Ohta M, Fukui M, Kitagawa Y, Park H, Nakamura N, Nakano K, Yoshikawa T: Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care\u200826:1246\u20131250,2003","DOI":"10.2337\/diacare.26.4.1246"},{"key":"2022031218140183700_R30","doi-asserted-by":"crossref","unstructured":"Vivoli G, Bergomi M, Rovesti S, Pinotti M, Caselgrandi E: Zinc, copper, and zinc- or copper-dependent enzymes in human hypertension. Biol Trace Elem Res\u200849:97\u2013106,1995","DOI":"10.1007\/BF02788959"},{"key":"2022031218140183700_R31","doi-asserted-by":"crossref","unstructured":"Lloyd-Jones DM, Bloch KD: The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med\u200847:365\u2013375,1996","DOI":"10.1146\/annurev.med.47.1.365"},{"key":"2022031218140183700_R32","doi-asserted-by":"crossref","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature\u2008404:787\u2013791,2000","DOI":"10.1038\/35008121"},{"key":"2022031218140183700_R33","unstructured":"Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC, National Academy of Sciences, 2001"},{"key":"2022031218140183700_R34","unstructured":"Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC, National Academy of Sciences, 2000"},{"key":"2022031218140183700_R35","unstructured":"Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, National Academy of Sciences, 1997"},{"key":"2022031218140183700_R36","doi-asserted-by":"crossref","unstructured":"Escobar O, Sandoval M, Vargas A, Hempe JM: Role of metallothionein and cysteine-rich intestinal protein in regulation of zinc absorption by diabetic rats. Pediatr Res\u200837:321\u2013327,1995","DOI":"10.1203\/00006450-199503000-00012"},{"key":"2022031218140183700_R37","doi-asserted-by":"crossref","unstructured":"Keen CL, Cohen NL, Lonnerdal B, Hurley LS: Teratogenesis and low copper status resulting from triethylenetetramine in rats. Proc Soc Exp Biol Med\u2008173:598\u2013605,1983","DOI":"10.3181\/00379727-173-41693"},{"key":"2022031218140183700_R38","doi-asserted-by":"crossref","unstructured":"Ford ES, Cogswell ME: Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care\u200822:1978\u20131983,1999","DOI":"10.2337\/diacare.22.12.1978"},{"key":"2022031218140183700_R39","doi-asserted-by":"crossref","unstructured":"Cutler P: Deferoxamine therapy in high-ferritin diabetes. Diabetes\u200838:1207\u20131210,1989","DOI":"10.2337\/diabetes.38.10.1207"},{"key":"2022031218140183700_R40","doi-asserted-by":"crossref","unstructured":"Van Oost BA, Van den Beld B, Cloin LG, Marx JJ: Measurement of ferritin in serum: application in diagnostic use. Clin Biochem\u200817:263\u2013269,1984","DOI":"10.1016\/S0009-9120(84)90189-9"},{"key":"2022031218140183700_R41","doi-asserted-by":"crossref","unstructured":"Linder MC: Biochemistry of Copper. New York, Plenum, 1991","DOI":"10.1007\/978-1-4757-9432-8"},{"key":"2022031218140183700_R42","doi-asserted-by":"crossref","unstructured":"Islam KN, Takahashi M, Higashiyama S, Myint T, Uozumi N, Hayanoki Y, Kaneto H, Kisaka H, Taniguchi N: Fragmentation of ceruloplasmin following nonenzymatic glycation reaction. J Biochem\u2008118:1054\u20131060,1995","DOI":"10.1093\/jb\/118.5.1054"},{"key":"2022031218140183700_R43","doi-asserted-by":"crossref","unstructured":"Argirova MD, Ortwerth BJ: Activation of protein-bound copper ions during early glycation: study on two proteins. Arch Biochem Biophys\u2008420:176\u2013184,2003","DOI":"10.1016\/j.abb.2003.09.005"},{"key":"2022031218140183700_R44","doi-asserted-by":"crossref","unstructured":"Bourdon E, Loreau N, Blache D: Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J\u200813:233\u2013244,1999","DOI":"10.1096\/fasebj.13.2.233"},{"key":"2022031218140183700_R45","doi-asserted-by":"crossref","unstructured":"Hirose J, Fujiwara H, Magarifuchi T, Iguti Y, Iwamoto H, Kominami S, Hiromi K: Copper binding selectivity of N and C sites in serum and ovotransferrin. Biochim Biophys Acta\u20081296:103\u2013111,1996","DOI":"10.1016\/0167-4838(96)00058-1"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/54\/5\/1468\/381961\/zdb00505001468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/54\/5\/1468\/381961\/zdb00505001468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T13:53:44Z","timestamp":1707659624000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/54\/5\/1468\/25925\/Demonstration-of-a-Hyperglycemia-Driven-Pathogenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.54.5.1468","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}